Work

Abstract CT120: First in human phase 1 dose escalation and expansion clinical trial to evaluate the safety, pharmacokinetics and antitumor activity of intravenous AROG4-01 in patients with advanced solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct120

Authors: Vicente Valentí, María Jove, Cinta Hierro, Víctor Moreno, Marta Gil-Martin, Emiliano Calvo, Ernest Nadal, Sonia Macia, Carme Plasencia

Institutions: Hospital Sant Pau i Santa Tecla, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Applied Research Using OMIC Sciences (Spain)

Language: English

Topic: DNA and Nucleic Acid Chemistry

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822213

Cites:

Cited by:

Related to: 10